KOL Knockout™: Cataract Edition — Improving Postoperative Outcomes Through Advances in Aberrometry, Femtosecond Lasers, and IOLs - Round 1

KOL Knockout Cataract Edition  Improving Postoperative Outcomes Through Advances in Aberrometry Femtosecond Lasers and IOLs
Media formats available:
Details
Presenters
  • Overview

    This fun and exciting CME program is a game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Gary Wörtz, MD, the first of three rounds features Preeya K. Gupta, MD; William B. Trattler, MD; and Robert J. WeinstockMD, as contestants. 

    The program includes patient case studies with each KOL weighing in on the treatment options. 

    There will be learning, laughter, and only one KOL left standing! 

    This content was captured during a live virtual symposium. Voting took place during the symposium.

     

    This activity is supported by an unrestricted medical educational grant from Alcon Vision.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Identify the potential benefits and drawbacks of using femtosecond laser technology for cataract and refractive surgery
    • Discuss advances in adjunctive technologies for cataract surgery and how they can be used to improve refractive outcomes
    • Compare advanced intraocular lenses for cataract and refractive surgery patients to properly counsel patients and create personalized treatment plans based on patient expectations
    • Accreditation

      Provided by Evolve Medical Education 

      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
      Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

       

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Gary Wörtz, MD

      Gary Wörtz, MD

      Private practice

      Commonwealth Eye Surgery

      Lexington, KY


      Preeya K. Gupta, MD

      Preeya K. Gupta, MD

      Managing Director
      Triangle Eye Consultants
      Cary, NC


      William B. Trattler, MD

      William B. Trattler, MD

      Cornea, Cataract, and Refractive Surgeon
      Center for Excellence in Eye Care
      Clinical Associate Professor
      Herbert Wertheim College of Medicine
      Florida International University
      Miami, FL


      Robert J. Weinstock, MD

      Robert J. Weinstock, MD

      Private Practice

      The Eye Institute of West Florida
      Largo, FL


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Gary Wörtz, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Carl Zeiss Meditec, Johnson & Johnson, Lensar, and Ocuphire. Speaker's Bureau: Avellino. Stock/Shareholder: Arcuate Innovations and Omega Ophthalmics.

      Preeya K. Gupta, MD, has had a financial agreement or affiliation with the following ineligible companies in the form of Consultant: Alcon, Aldeyra, Allergan, Azura, Carl Zeiss Meditec, Expert Opinion, HanAll Biopharma, Johnson & Johnson Vision, Kala Pharmaceuticals, New World Medical, Novartis, Ocular Science, Ocular Therapeutix, Orasis, Oyster Point, Sight Sciences, Spyglass, Surface Ophthalmics, Sun Pharmaceutical Industries, Tear Clear, TearLab, Tissue Tech, and Visionology. Stock/Shareholder: Azura, Expert Opinion, Orasis, Oyster Point, Tarsus, Tear Clear, Surface, Spyglass, Visionology, and Visant.

      William B. Trattler, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Allergan, Avellino, Azura Ophthalmics, Bausch + Lomb, Beaver-Visitec International, Bio-Tissue, Carl Zeiss Meditec, Glaukos, Johnson & Johnson Vision, Kala Pharmaceuticals, Lensar, Oculus, Sight Sciences, and Sun Ophthalmics. Speaker’s Bureau: Alcon, Allergan, Avellino, Bausch + Lomb, Beaver-Visitec International, Carl Zeiss Meditec, Johnson & Johnson Vision, Kala Pharmaceuticals, Lensar, Oculus, Sight Sciences, and Sun Ophthalmics. Stock/Shareholder: ArcScan and Visionary Fund.

      Robert J. Weinstock, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Bausch + Lomb, Beyeonics, EyePoint Pharmaceuticals, Johnson & Johnson Vision, Lensar, and Visus. Speaker's Bureau: Johnson & Johnson Vision. Shareholder: Eyesafe, RPS, RxSight, TissueTech, uBeam, and Visus.

      The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Alcon Vision. 

       

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free